Variant report
Variant | rs460470 |
---|---|
Chromosome Location | chr20:52681167-52681168 |
allele | A/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:52645200-52682200 | Weak transcription | Sigmoid Colon | Sigmoid Colon |
2 | chr20:52669400-52681800 | Weak transcription | Gastric | stomach |
3 | chr20:52674400-52681200 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
4 | chr20:52674400-52682000 | Weak transcription | Colonic Mucosa | Colon |
5 | chr20:52675000-52683000 | Weak transcription | HepG2 | liver |
6 | chr20:52678200-52683800 | Weak transcription | HMEC | breast |
7 | chr20:52678200-52684400 | Weak transcription | Fetal Stomach | stomach |
8 | chr20:52678400-52683200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr20:52679200-52681600 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
10 | chr20:52679400-52683000 | Weak transcription | HSMM | muscle |
11 | chr20:52679400-52683000 | Weak transcription | NH-A | brain |
12 | chr20:52679600-52681400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
13 | chr20:52679600-52682200 | Enhancers | Primary B cells from peripheral blood | blood |
14 | chr20:52679600-52682200 | Enhancers | Primary hematopoietic stem cells | blood |
15 | chr20:52679600-52682400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
16 | chr20:52679600-52682600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
17 | chr20:52679800-52681400 | Weak transcription | K562 | blood |
18 | chr20:52679800-52682200 | Weak transcription | Fetal Heart | heart |
19 | chr20:52679800-52683000 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
20 | chr20:52679800-52683000 | Weak transcription | HSMMtube | muscle |
21 | chr20:52680000-52681400 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
22 | chr20:52680000-52682000 | Weak transcription | Fetal Intestine Small | intestine |
23 | chr20:52680000-52683000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
24 | chr20:52680200-52681600 | Flanking Active TSS | GM12878-XiMat | blood |
25 | chr20:52680400-52684400 | Enhancers | A549 | lung |
26 | chr20:52680600-52681200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
27 | chr20:52680800-52681200 | Enhancers | H1 Cell Line | embryonic stem cell |
28 | chr20:52680800-52681200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
29 | chr20:52680800-52681400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
30 | chr20:52680800-52682400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
31 | chr20:52681000-52681200 | Enhancers | Primary T cells fromperipheralblood | blood |
32 | chr20:52681000-52681200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
33 | chr20:52681000-52681600 | Genic enhancers | Stomach Mucosa | stomach |
34 | chr20:52681000-52682200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |